| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | ABCC1 CACNG1 TRPA1 FLVCR1 ATP9B APOA4 SLC35E2B PKD1L3 ABCA8 CHRNA7 RYR3 ANO8 GJD4 ITPR3 GJA9 SLC5A11 CATSPER2 SLC15A2 SLC22A14 SLC10A5 SLC35B4 SLC35E2A GJD3 ATP2C2 SLC49A4 SLC39A6 DISP2 GJA10 TMCO3 CHRFAM7A ABCC10 MCOLN2 | 2.65e-09 | 1289 | 153 | 32 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCC1 CACNG1 TRPA1 FLVCR1 SLC35E2B PKD1L3 ABCA8 CHRNA7 RYR3 ANO8 GJD4 ITPR3 GJA9 SLC5A11 CATSPER2 SLC15A2 SLC22A14 SLC10A5 SLC35B4 SLC35E2A GJD3 ATP2C2 SLC49A4 SLC39A6 DISP2 GJA10 TMCO3 CHRFAM7A ABCC10 MCOLN2 | 5.31e-09 | 1180 | 153 | 30 | GO:0022857 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | CACNG1 TRPA1 PKD1L3 CHRNA7 RYR3 ITPR3 CATSPER2 ATP2C2 MCOLN2 | 2.51e-06 | 151 | 153 | 9 | GO:0015085 |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 4.36e-06 | 5 | 153 | 3 | GO:0052871 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 4.36e-06 | 5 | 153 | 3 | GO:0008294 | |
| GeneOntologyMolecularFunction | aromatase activity | 6.67e-06 | 35 | 153 | 5 | GO:0070330 | |
| GeneOntologyMolecularFunction | calcium channel activity | 6.89e-06 | 129 | 153 | 8 | GO:0005262 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 9.33e-06 | 18 | 153 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR5P2 OR51T1 TRPA1 FPR2 GPR141 LMBR1 PKD1L3 OR10T2 CRLF2 CRHR1 PTPRT CHRNA7 CRHR2 OR51A7 TAS2R9 TAS2R13 GPR150 PTPRM FZD10 CD79B GPRC5D LTK CHRFAM7A CNR1 HCRTR2 S1PR4 | 1.23e-05 | 1353 | 153 | 26 | GO:0004888 |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 1.51e-05 | 7 | 153 | 3 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 1.51e-05 | 7 | 153 | 3 | GO:0018685 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 3.59e-05 | 49 | 153 | 5 | GO:0016712 | |
| GeneOntologyMolecularFunction | gap junction channel activity | 3.70e-05 | 25 | 153 | 4 | GO:0005243 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 5.09e-05 | 10 | 153 | 3 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 5.09e-05 | 10 | 153 | 3 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 5.09e-05 | 10 | 153 | 3 | GO:0102033 | |
| GeneOntologyMolecularFunction | channel activity | CACNG1 TRPA1 PKD1L3 CHRNA7 RYR3 ANO8 GJD4 ITPR3 GJA9 CATSPER2 GJD3 GJA10 CHRFAM7A MCOLN2 | 5.37e-05 | 525 | 153 | 14 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNG1 TRPA1 PKD1L3 CHRNA7 RYR3 ANO8 GJD4 ITPR3 GJA9 CATSPER2 GJD3 GJA10 CHRFAM7A MCOLN2 | 5.48e-05 | 526 | 153 | 14 | GO:0022803 |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 5.83e-05 | 2 | 153 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 5.83e-05 | 2 | 153 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNG1 TRPA1 PKD1L3 CHRNA7 RYR3 ITPR3 SLC5A11 CATSPER2 SLC10A5 ATP2C2 SLC39A6 TMCO3 MCOLN2 | 6.23e-05 | 465 | 153 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ABCC1 CACNG1 TRPA1 PKD1L3 CHRNA7 RYR3 ANO8 ITPR3 SLC5A11 CATSPER2 SLC15A2 SLC10A5 ATP2C2 SLC39A6 TMCO3 ABCC10 MCOLN2 | 7.32e-05 | 758 | 153 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 8.88e-05 | 31 | 153 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.04e-04 | 140 | 153 | 7 | GO:0099094 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.14e-04 | 33 | 153 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 1.19e-04 | 13 | 153 | 3 | GO:0016713 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.23e-04 | 193 | 153 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNG1 TRPA1 PKD1L3 CHRNA7 RYR3 ANO8 ITPR3 SLC5A11 CATSPER2 SLC15A2 SLC10A5 GJD3 ATP2C2 SLC39A6 TMCO3 CHRFAM7A MCOLN2 | 1.26e-04 | 793 | 153 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.42e-04 | 197 | 153 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | corticotropin-releasing hormone receptor activity | 1.74e-04 | 3 | 153 | 2 | GO:0043404 | |
| GeneOntologyMolecularFunction | corticotrophin-releasing factor receptor activity | 1.74e-04 | 3 | 153 | 2 | GO:0015056 | |
| GeneOntologyMolecularFunction | EGF-domain serine glucosyltransferase activity | 1.74e-04 | 3 | 153 | 2 | GO:0140561 | |
| GeneOntologyMolecularFunction | EGF-domain serine xylosyltransferase activity | 1.74e-04 | 3 | 153 | 2 | GO:0140562 | |
| GeneOntologyMolecularFunction | wide pore channel activity | 1.80e-04 | 37 | 153 | 4 | GO:0022829 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.80e-04 | 37 | 153 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.80e-04 | 153 | 153 | 7 | GO:0008194 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNG1 TRPA1 PKD1L3 CHRNA7 RYR3 ITPR3 SLC5A11 CATSPER2 SLC15A2 SLC10A5 ATP2C2 SLC39A6 TMCO3 CHRFAM7A MCOLN2 | 1.83e-04 | 664 | 153 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | arachidonate binding | 1.88e-04 | 15 | 153 | 3 | GO:0050544 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 1.88e-04 | 15 | 153 | 3 | GO:0008559 | |
| GeneOntologyMolecularFunction | icosanoid binding | 2.30e-04 | 16 | 153 | 3 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 2.30e-04 | 16 | 153 | 3 | GO:0050543 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 2.30e-04 | 16 | 153 | 3 | GO:0008179 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 3.31e-04 | 18 | 153 | 3 | GO:0004016 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.31e-04 | 18 | 153 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNG1 TRPA1 PKD1L3 CHRNA7 RYR3 ITPR3 SLC5A11 CATSPER2 SLC15A2 SLC10A5 ATP2C2 SLC39A6 TMCO3 MCOLN2 | 3.40e-04 | 627 | 153 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | glycosyltransferase activity | GALNTL6 POGLUT3 GLT8D1 UGT3A1 GALNT7 SIRT4 GALNT17 TMTC3 POGLUT2 | 3.89e-04 | 288 | 153 | 9 | GO:0016757 |
| GeneOntologyMolecularFunction | polypeptide N-acetylgalactosaminyltransferase activity | 4.57e-04 | 20 | 153 | 3 | GO:0004653 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor binding | 5.75e-04 | 5 | 153 | 2 | GO:0031821 | |
| GeneOntologyMolecularFunction | cyclase activity | 7.93e-04 | 24 | 153 | 3 | GO:0009975 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 7.93e-04 | 24 | 153 | 3 | GO:0008392 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNG1 TRPA1 PKD1L3 CHRNA7 RYR3 ANO8 ITPR3 CATSPER2 GJD3 CHRFAM7A MCOLN2 | 8.41e-04 | 459 | 153 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 8.96e-04 | 25 | 153 | 3 | GO:0016849 | |
| GeneOntologyMolecularFunction | gated channel activity | CACNG1 TRPA1 CHRNA7 RYR3 ANO8 ITPR3 CATSPER2 CHRFAM7A MCOLN2 | 1.12e-03 | 334 | 153 | 9 | GO:0022836 |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.13e-03 | 27 | 153 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC1 SLC35E2B ABCA8 SLC5A11 SLC15A2 SLC10A5 SLC35E2A ATP2C2 SLC39A6 TMCO3 ABCC10 | 1.15e-03 | 477 | 153 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | heme binding | 1.21e-03 | 154 | 153 | 6 | GO:0020037 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.23e-03 | 211 | 153 | 7 | GO:0016758 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 1.26e-03 | 28 | 153 | 3 | GO:0036041 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.26e-03 | 28 | 153 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5P2 OR51T1 FPR2 GPR141 OR10T2 CRHR1 CRHR2 OR51A7 TAS2R9 TAS2R13 GPR150 FZD10 GPRC5D CNR1 HCRTR2 S1PR4 | 1.26e-03 | 884 | 153 | 16 | GO:0004930 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNG1 TRPA1 PKD1L3 CHRNA7 RYR3 ITPR3 CATSPER2 CHRFAM7A MCOLN2 | 1.34e-03 | 343 | 153 | 9 | GO:0005261 |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.40e-03 | 107 | 153 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | lipid binding | CYP4F8 GBF1 IAPP GPR141 CYP4F2 APOA4 VPS36 ACTN2 ITPR3 DEFA5 CHPT1 SNX25 CYP26C1 PLA2G1B UNC13C ALOX5AP S1PR4 | 1.53e-03 | 988 | 153 | 17 | GO:0008289 |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 1.58e-03 | 8 | 153 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 1.67e-03 | 164 | 153 | 6 | GO:0046906 | |
| GeneOntologyMolecularFunction | iron ion binding | 1.78e-03 | 166 | 153 | 6 | GO:0005506 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.93e-03 | 115 | 153 | 5 | GO:0004497 | |
| GeneOntologyMolecularFunction | tripeptide transmembrane transporter activity | 2.03e-03 | 9 | 153 | 2 | GO:0042937 | |
| GeneOntologyMolecularFunction | taste receptor activity | 2.03e-03 | 33 | 153 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC1 SPG7 DNAH2 ATP9B ABCA8 DMC1 ATP2C2 DNAH8 DYNC1H1 ABCC10 | 2.17e-03 | 441 | 153 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 2.22e-03 | 34 | 153 | 3 | GO:0042910 | |
| GeneOntologyMolecularFunction | acetylgalactosaminyltransferase activity | 2.41e-03 | 35 | 153 | 3 | GO:0008376 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 2.52e-03 | 10 | 153 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 2.73e-03 | 310 | 153 | 8 | GO:0030246 | |
| GeneOntologyMolecularFunction | UDP-xylosyltransferase activity | 3.07e-03 | 11 | 153 | 2 | GO:0035252 | |
| GeneOntologyMolecularFunction | xylosyltransferase activity | 3.07e-03 | 11 | 153 | 2 | GO:0042285 | |
| GeneOntologyMolecularFunction | peptide binding | 3.19e-03 | 318 | 153 | 8 | GO:0042277 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 3.54e-03 | 40 | 153 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3.86e-03 | 194 | 153 | 6 | GO:0016705 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 4.06e-03 | 196 | 153 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | UDP-glucosyltransferase activity | 4.30e-03 | 13 | 153 | 2 | GO:0035251 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 4.30e-03 | 13 | 153 | 2 | GO:0042166 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 4.64e-03 | 44 | 153 | 3 | GO:0046915 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 5.00e-03 | 14 | 153 | 2 | GO:0008401 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 5.26e-03 | 46 | 153 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | chloride channel regulator activity | 5.74e-03 | 15 | 153 | 2 | GO:0017081 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 6.28e-03 | 49 | 153 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | diacylglycerol binding | 6.52e-03 | 16 | 153 | 2 | GO:0019992 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 6.52e-03 | 16 | 153 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 7.36e-03 | 17 | 153 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 7.36e-03 | 17 | 153 | 2 | GO:0022848 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 7.36e-03 | 17 | 153 | 2 | GO:0019198 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 1.87e-08 | 41 | 152 | 7 | GO:0006691 | |
| GeneOntologyBiologicalProcess | cilium movement | CFAP47 SEMG2 INPP5B DNAH2 CHRNA7 DNAAF5 YIF1B CATSPER2 SLC22A14 DNAH8 CHRFAM7A DYNC1H1 | 5.55e-07 | 261 | 152 | 12 | GO:0003341 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ABCC1 CACNG1 TRPA1 SPG7 FLVCR1 ACTN2 PKD1L3 CRHR1 CHRNA7 CRHR2 RYR3 ANO8 ITPR3 SLC5A11 CATSPER2 TMEM168 SLC15A2 SLC10A5 GJD3 ATP2C2 PLA2G1B SLC39A6 TMEM163 TMCO3 CHRFAM7A ABCC10 CNR1 MCOLN2 | 8.04e-07 | 1374 | 152 | 28 | GO:0006811 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | CFAP47 SEMG2 INPP5B DNAH2 CHRNA7 YIF1B CATSPER2 SLC22A14 DNAH8 CHRFAM7A | 3.69e-06 | 210 | 152 | 10 | GO:0060294 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNG1 TRPA1 SPG7 FLVCR1 ACTN2 PKD1L3 CRHR1 CHRNA7 CRHR2 RYR3 ITPR3 SLC5A11 CATSPER2 TMEM168 SLC10A5 ATP2C2 PLA2G1B SLC39A6 TMEM163 TMCO3 CHRFAM7A MCOLN2 | 4.27e-06 | 1000 | 152 | 22 | GO:0030001 |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | CFAP47 SEMG2 INPP5B DNAH2 CHRNA7 YIF1B CATSPER2 SLC22A14 DNAH8 CHRFAM7A | 4.55e-06 | 215 | 152 | 10 | GO:0060285 |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | CFAP47 SEMG2 INPP5B DNAH2 CHRNA7 YIF1B CATSPER2 SLC22A14 DNAH8 CHRFAM7A | 4.55e-06 | 215 | 152 | 10 | GO:0001539 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ABCC1 CACNG1 TRPA1 SPG7 ACTN2 PKD1L3 CRHR1 CHRNA7 RYR3 ANO8 ITPR3 CATSPER2 TMEM168 SLC15A2 GJD3 ATP2C2 PLA2G1B SLC39A6 TMEM163 TMCO3 CHRFAM7A ABCC10 MCOLN2 | 7.29e-06 | 1115 | 152 | 23 | GO:0034220 |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 7.72e-06 | 6 | 152 | 3 | GO:0036101 | |
| GeneOntologyBiologicalProcess | cellular response to forskolin | 8.00e-06 | 18 | 152 | 4 | GO:1904322 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | IAPP FPR2 ADCY1 ADCY5 ADCY8 CRHR1 CRHR2 GNAI1 GNAI3 CNR1 S1PR4 | 9.24e-06 | 286 | 152 | 11 | GO:0007188 |
| GeneOntologyBiologicalProcess | response to forskolin | 1.01e-05 | 19 | 152 | 4 | GO:1904321 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR5P2 OR51T1 IAPP FPR2 GPR141 KLK14 ACTN2 OR10T2 ADCY1 ADCY5 NPVF ADCY8 CRHR1 CRHR2 ITPR3 OR51A7 TAS2R9 TAS2R13 GPR150 FZD10 GNAI1 GPRC5D GNAI3 CNR1 HCRTR2 S1PR4 | 1.06e-05 | 1395 | 152 | 26 | GO:0007186 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNG1 TRPA1 SPG7 FLVCR1 ACTN2 PKD1L3 CRHR1 CHRNA7 CRHR2 RYR3 ITPR3 SLC5A11 CATSPER2 TMEM168 SLC15A2 SLC10A5 ATP2C2 PLA2G1B SLC39A6 TMEM163 TMCO3 CHRFAM7A MCOLN2 | 1.32e-05 | 1157 | 152 | 23 | GO:0006812 |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 1.34e-05 | 7 | 152 | 3 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 2.14e-05 | 8 | 152 | 3 | GO:0036100 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNG1 TRPA1 SPG7 PKD1L3 CRHR1 CHRNA7 CRHR2 RYR3 ITPR3 CATSPER2 ATP2C2 PLA2G1B CHRFAM7A MCOLN2 | 2.52e-05 | 509 | 152 | 14 | GO:0006816 |
| GeneOntologyBiologicalProcess | positive regulation of CoA-transferase activity | 3.19e-05 | 9 | 152 | 3 | GO:1905920 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNG1 TRPA1 SPG7 PKD1L3 CRHR1 CHRNA7 RYR3 ITPR3 CATSPER2 ATP2C2 PLA2G1B MCOLN2 | 3.50e-05 | 392 | 152 | 12 | GO:0070588 |
| GeneOntologyBiologicalProcess | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 5.40e-05 | 2 | 152 | 2 | GO:0001988 | |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 6.20e-05 | 11 | 152 | 3 | GO:0006171 | |
| GeneOntologyBiologicalProcess | regulation of CoA-transferase activity | 6.20e-05 | 11 | 152 | 3 | GO:1905918 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 6.20e-05 | 11 | 152 | 3 | GO:1901523 | |
| GeneOntologyBiologicalProcess | flagellated sperm motility | 7.30e-05 | 186 | 152 | 8 | GO:0030317 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | CFAP47 SEMG2 SPG7 INPP5B DNAH2 CHRNA7 DNAAF5 YIF1B CATSPER2 SLC22A14 DNAH8 CHRFAM7A DYNC1H1 | 7.60e-05 | 493 | 152 | 13 | GO:0007018 |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 8.22e-05 | 12 | 152 | 3 | GO:0042758 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 8.90e-05 | 142 | 152 | 7 | GO:0006690 | |
| GeneOntologyBiologicalProcess | sperm motility | 9.45e-05 | 193 | 152 | 8 | GO:0097722 | |
| GeneOntologyBiologicalProcess | long-term synaptic potentiation | 9.72e-05 | 144 | 152 | 7 | GO:0060291 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term synaptic potentiation | 1.11e-04 | 34 | 152 | 4 | GO:1900273 | |
| GeneOntologyBiologicalProcess | protein O-linked glycosylation | 1.28e-04 | 105 | 152 | 6 | GO:0006493 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine secretion | 1.36e-04 | 67 | 152 | 5 | GO:0050433 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNG1 TRPA1 SPG7 ACTN2 PKD1L3 CRHR1 CHRNA7 RYR3 ITPR3 CATSPER2 TMEM168 SLC15A2 ATP2C2 PLA2G1B SLC39A6 TMEM163 TMCO3 MCOLN2 | 1.57e-04 | 922 | 152 | 18 | GO:0098662 |
| GeneOntologyBiologicalProcess | baroreceptor response to decreased systemic arterial blood pressure | 1.61e-04 | 3 | 152 | 2 | GO:0001982 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNG1 TRPA1 SPG7 ACTN2 PKD1L3 CRHR1 CHRNA7 RYR3 ANO8 ITPR3 CATSPER2 TMEM168 SLC15A2 ATP2C2 PLA2G1B SLC39A6 TMEM163 TMCO3 MCOLN2 | 1.79e-04 | 1017 | 152 | 19 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNG1 TRPA1 SPG7 ACTN2 PKD1L3 CRHR1 CHRNA7 RYR3 ITPR3 CATSPER2 TMEM168 SLC15A2 ATP2C2 PLA2G1B SLC39A6 TMEM163 TMCO3 MCOLN2 | 2.04e-04 | 942 | 152 | 18 | GO:0098655 |
| GeneOntologyBiologicalProcess | cAMP-mediated signaling | 2.47e-04 | 76 | 152 | 5 | GO:0019933 | |
| GeneOntologyBiologicalProcess | behavioral response to ethanol | 2.47e-04 | 17 | 152 | 3 | GO:0048149 | |
| GeneOntologyBiologicalProcess | catecholamine secretion | 2.96e-04 | 79 | 152 | 5 | GO:0050432 | |
| GeneOntologyBiologicalProcess | generation of ovulation cycle rhythm | 3.21e-04 | 4 | 152 | 2 | GO:0060112 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | APOA4 ABCA8 CRHR1 CHRNA7 CRHR2 SLC5A11 SLC10A5 SLC49A4 CHRFAM7A CNR1 | 3.32e-04 | 358 | 152 | 10 | GO:0015850 |
| GeneOntologyBiologicalProcess | regulation of amyloid fibril formation | 3.49e-04 | 19 | 152 | 3 | GO:1905906 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | ABCC1 TRPA1 ERN1 FPR2 UGT3A1 APOA4 ACTN2 ADCY1 ADCY5 ADCY8 CRHR1 CHRNA7 CRHR2 RYR3 ITPR3 DEFA5 FAT1 PLA2G1B FZD10 GNAI1 GNAI3 LTK CHRFAM7A | 3.97e-04 | 1450 | 152 | 23 | GO:1901701 |
| GeneOntologyBiologicalProcess | memory | 4.23e-04 | 183 | 152 | 7 | GO:0007613 | |
| GeneOntologyBiologicalProcess | regulation of response to drug | 4.73e-04 | 21 | 152 | 3 | GO:2001023 | |
| GeneOntologyBiologicalProcess | sensory processing | 5.32e-04 | 5 | 152 | 2 | GO:0050893 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 5.45e-04 | 22 | 152 | 3 | GO:1901569 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 5.47e-04 | 191 | 152 | 7 | GO:0007189 | |
| GeneOntologyBiologicalProcess | negative regulation of catecholamine secretion | 6.24e-04 | 23 | 152 | 3 | GO:0033604 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 6.24e-04 | 23 | 152 | 3 | GO:0009190 | |
| GeneOntologyBiologicalProcess | catecholamine transport | 7.26e-04 | 96 | 152 | 5 | GO:0051937 | |
| GeneOntologyBiologicalProcess | cellular response to corticotropin-releasing hormone stimulus | 7.94e-04 | 6 | 152 | 2 | GO:0071376 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback | 7.94e-04 | 6 | 152 | 2 | GO:0001978 | |
| GeneOntologyBiologicalProcess | response to corticotropin-releasing hormone | 7.94e-04 | 6 | 152 | 2 | GO:0043435 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 8.01e-04 | 25 | 152 | 3 | GO:0046058 | |
| GeneOntologyBiologicalProcess | regulation of norepinephrine secretion | 9.01e-04 | 26 | 152 | 3 | GO:0014061 | |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure | 9.42e-04 | 59 | 152 | 4 | GO:0045777 | |
| GeneOntologyBiologicalProcess | copulation | 1.01e-03 | 27 | 152 | 3 | GO:0007620 | |
| GeneOntologyBiologicalProcess | response to amyloid-beta | 1.07e-03 | 61 | 152 | 4 | GO:1904645 | |
| GeneOntologyBiologicalProcess | leukotriene transport | 1.11e-03 | 7 | 152 | 2 | GO:0071716 | |
| GeneOntologyBiologicalProcess | norepinephrine secretion | 1.12e-03 | 28 | 152 | 3 | GO:0048243 | |
| GeneOntologyBiologicalProcess | xenobiotic transport | 1.28e-03 | 64 | 152 | 4 | GO:0042908 | |
| GeneOntologyCellularComponent | apical plasma membrane | ABCC1 CYP4F8 TRPA1 CYP4F2 ADCY8 CHRNA7 ITPR3 SLC5A11 FAT1 SLC15A2 MUC17 SLC39A6 CYP4F3 CHRFAM7A | 1.67e-05 | 487 | 155 | 14 | GO:0016324 |
| GeneOntologyCellularComponent | connexin complex | 1.92e-05 | 22 | 155 | 4 | GO:0005922 | |
| GeneOntologyCellularComponent | apical part of cell | ABCC1 CYP4F8 TRPA1 CYP4F2 ADCY8 CRHR1 CHRNA7 ITPR3 SLC5A11 FAT1 SLC15A2 MUC17 SLC39A6 CYP4F3 CHRFAM7A | 3.58e-05 | 592 | 155 | 15 | GO:0045177 |
| GeneOntologyCellularComponent | gap junction | 1.59e-04 | 37 | 155 | 4 | GO:0005921 | |
| GeneOntologyCellularComponent | spine apparatus membrane | 1.63e-04 | 3 | 155 | 2 | GO:0098897 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 7.68e-04 | 201 | 155 | 7 | GO:0099634 | |
| HumanPheno | Delayed ability to walk | HK1 SYNE1 FLVCR1 ACTN2 WDR26 ADCY5 RYR3 TMTC3 TMEM163 GNAI1 AP4B1 DYNC1H1 | 6.15e-06 | 304 | 44 | 12 | HP:0031936 |
| MousePheno | airway basal cell hyperplasia | 6.59e-05 | 2 | 114 | 2 | MP:0011115 | |
| MousePheno | abnormal airway basal cell differentiation | 6.59e-05 | 2 | 114 | 2 | MP:0011114 | |
| MousePheno | abnormal airway basal cell morphology | 6.59e-05 | 2 | 114 | 2 | MP:0011113 | |
| MousePheno | increased chemical nociceptive threshold | 9.76e-05 | 30 | 114 | 4 | MP:0008531 | |
| Domain | Connexin | 1.89e-05 | 20 | 153 | 4 | IPR000500 | |
| Domain | Connexin_CCC | 1.89e-05 | 20 | 153 | 4 | IPR019570 | |
| Domain | Connexin_N | 1.89e-05 | 20 | 153 | 4 | IPR013092 | |
| Domain | Connexin_CCC | 1.89e-05 | 20 | 153 | 4 | SM01089 | |
| Domain | CONNEXINS_2 | 1.89e-05 | 20 | 153 | 4 | PS00408 | |
| Domain | Connexin | 1.89e-05 | 20 | 153 | 4 | PF00029 | |
| Domain | Connexin_CS | 1.89e-05 | 20 | 153 | 4 | IPR017990 | |
| Domain | CNX | 1.89e-05 | 20 | 153 | 4 | SM00037 | |
| Domain | AAA | 2.48e-05 | 144 | 153 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 2.48e-05 | 144 | 153 | 8 | IPR003593 | |
| Domain | DHC_N1 | 2.93e-05 | 8 | 153 | 3 | PF08385 | |
| Domain | AC_N | 2.93e-05 | 8 | 153 | 3 | IPR032628 | |
| Domain | Adcy | 2.93e-05 | 8 | 153 | 3 | IPR030672 | |
| Domain | AC_N | 2.93e-05 | 8 | 153 | 3 | PF16214 | |
| Domain | Dynein_heavy_dom-1 | 2.93e-05 | 8 | 153 | 3 | IPR013594 | |
| Domain | Cyt_P450_CS | 7.22e-05 | 53 | 153 | 5 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 1.03e-04 | 57 | 153 | 5 | PS00086 | |
| Domain | p450 | 1.12e-04 | 58 | 153 | 5 | PF00067 | |
| Domain | Cyt_P450 | 1.31e-04 | 60 | 153 | 5 | IPR001128 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.84e-04 | 14 | 153 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.84e-04 | 14 | 153 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.84e-04 | 14 | 153 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.84e-04 | 14 | 153 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.84e-04 | 14 | 153 | 3 | IPR011704 | |
| Domain | MT | 1.84e-04 | 14 | 153 | 3 | PF12777 | |
| Domain | AAA_8 | 1.84e-04 | 14 | 153 | 3 | PF12780 | |
| Domain | AAA_5 | 1.84e-04 | 14 | 153 | 3 | PF07728 | |
| Domain | LipoPS_modifying | 1.99e-04 | 3 | 153 | 2 | IPR006598 | |
| Domain | GPCR_2_CRF_rcpt | 1.99e-04 | 3 | 153 | 2 | IPR003051 | |
| Domain | AP_complex_bsu_1_2_4 | 1.99e-04 | 3 | 153 | 2 | IPR016342 | |
| Domain | Glyco_transf_90 | 1.99e-04 | 3 | 153 | 2 | PF05686 | |
| Domain | CAP10 | 1.99e-04 | 3 | 153 | 2 | SM00672 | |
| Domain | B2-adapt-app_C | 1.99e-04 | 3 | 153 | 2 | PF09066 | |
| Domain | DHC_fam | 2.28e-04 | 15 | 153 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.28e-04 | 15 | 153 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.28e-04 | 15 | 153 | 3 | IPR004273 | |
| Domain | A/G_cyclase_CS | 3.37e-04 | 17 | 153 | 3 | IPR018297 | |
| Domain | B2-adapt-app_C | 3.96e-04 | 4 | 153 | 2 | SM01020 | |
| Domain | B-adaptin_app_sub_C | 3.96e-04 | 4 | 153 | 2 | IPR015151 | |
| Domain | - | 4.02e-04 | 18 | 153 | 3 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 4.02e-04 | 18 | 153 | 3 | IPR029787 | |
| Domain | Guanylate_cyc | 4.74e-04 | 19 | 153 | 3 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 4.74e-04 | 19 | 153 | 3 | PS50125 | |
| Domain | A/G_cyclase | 4.74e-04 | 19 | 153 | 3 | IPR001054 | |
| Domain | CONNEXINS_1 | 4.74e-04 | 19 | 153 | 3 | PS00407 | |
| Domain | GUANYLATE_CYCLASE_1 | 4.74e-04 | 19 | 153 | 3 | PS00452 | |
| Domain | CYCc | 4.74e-04 | 19 | 153 | 3 | SM00044 | |
| Domain | ARM-type_fold | 4.93e-04 | 339 | 153 | 10 | IPR016024 | |
| Domain | Cyt_P450_E_grp-I | 4.97e-04 | 45 | 153 | 4 | IPR002401 | |
| Domain | AP_beta | 6.56e-04 | 5 | 153 | 2 | IPR026739 | |
| Domain | Adcy_conserved_dom | 9.79e-04 | 6 | 153 | 2 | IPR009398 | |
| Domain | RIH_assoc-dom | 9.79e-04 | 6 | 153 | 2 | IPR013662 | |
| Domain | DUF1053 | 9.79e-04 | 6 | 153 | 2 | PF06327 | |
| Domain | Ins145_P3_rec | 9.79e-04 | 6 | 153 | 2 | PF08709 | |
| Domain | RIH_assoc | 9.79e-04 | 6 | 153 | 2 | PF08454 | |
| Domain | RIH_dom | 9.79e-04 | 6 | 153 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 9.79e-04 | 6 | 153 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 9.79e-04 | 6 | 153 | 2 | IPR015925 | |
| Domain | - | 9.79e-04 | 6 | 153 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 9.79e-04 | 6 | 153 | 2 | PF01365 | |
| Domain | Beta2_adaptin/TBP_C_dom | 9.79e-04 | 6 | 153 | 2 | IPR012295 | |
| Domain | - | 9.79e-04 | 6 | 153 | 2 | 3.30.310.10 | |
| Domain | Ricin_B_lectin | 1.09e-03 | 25 | 153 | 3 | PF00652 | |
| Domain | - | 1.30e-03 | 58 | 153 | 4 | 1.10.630.10 | |
| Domain | RICIN | 1.52e-03 | 28 | 153 | 3 | SM00458 | |
| Domain | RICIN_B_LECTIN | 1.52e-03 | 28 | 153 | 3 | PS50231 | |
| Domain | Gprotein_alpha_I | 1.81e-03 | 8 | 153 | 2 | IPR001408 | |
| Domain | Coatomer/calthrin_app_sub_C | 1.81e-03 | 8 | 153 | 2 | IPR009028 | |
| Domain | Ricin_B_lectin | 1.86e-03 | 30 | 153 | 3 | IPR000772 | |
| Domain | Glycos_transf_2 | 1.86e-03 | 30 | 153 | 3 | PF00535 | |
| Domain | Glyco_trans_2-like | 1.86e-03 | 30 | 153 | 3 | IPR001173 | |
| Domain | Ion_trans_dom | 2.48e-03 | 114 | 153 | 5 | IPR005821 | |
| Domain | Ion_trans | 2.48e-03 | 114 | 153 | 5 | PF00520 | |
| Domain | MIR | 2.87e-03 | 10 | 153 | 2 | PF02815 | |
| Domain | IG_FLMN | 2.87e-03 | 10 | 153 | 2 | SM00557 | |
| Domain | MIR_motif | 2.87e-03 | 10 | 153 | 2 | IPR016093 | |
| Domain | MIR | 2.87e-03 | 10 | 153 | 2 | PS50919 | |
| Domain | Sugar_P_trans_dom | 2.87e-03 | 10 | 153 | 2 | IPR004853 | |
| Domain | MIR | 2.87e-03 | 10 | 153 | 2 | SM00472 | |
| Domain | TPT | 2.87e-03 | 10 | 153 | 2 | PF03151 | |
| Domain | Filamin | 3.49e-03 | 11 | 153 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 3.49e-03 | 11 | 153 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 3.49e-03 | 11 | 153 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 3.49e-03 | 11 | 153 | 2 | IPR017868 | |
| Domain | PKD_channel | 3.49e-03 | 11 | 153 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 3.49e-03 | 11 | 153 | 2 | IPR013122 | |
| Domain | - | 4.42e-03 | 81 | 153 | 4 | 3.90.550.10 | |
| Domain | Nucleotide-diphossugar_trans | 5.93e-03 | 88 | 153 | 4 | IPR029044 | |
| Domain | Clathrin/coatomer_adapt-like_N | 6.53e-03 | 15 | 153 | 2 | IPR002553 | |
| Domain | Adaptin_N | 6.53e-03 | 15 | 153 | 2 | PF01602 | |
| Domain | ER_TARGET | 6.71e-03 | 47 | 153 | 3 | PS00014 | |
| Domain | ABC_tran | 7.12e-03 | 48 | 153 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 7.12e-03 | 48 | 153 | 3 | PS50893 | |
| Domain | GproteinA_insert | 7.42e-03 | 16 | 153 | 2 | IPR011025 | |
| Domain | MAM_1 | 7.42e-03 | 16 | 153 | 2 | PS00740 | |
| Domain | - | 7.42e-03 | 16 | 153 | 2 | 1.10.400.10 | |
| Domain | HABP4_PAI-RBP1 | 7.42e-03 | 16 | 153 | 2 | PF04774 | |
| Domain | G-alpha | 7.42e-03 | 16 | 153 | 2 | PF00503 | |
| Domain | HABP4_PAIRBP1-bd | 7.42e-03 | 16 | 153 | 2 | IPR006861 | |
| Domain | G_alpha | 7.42e-03 | 16 | 153 | 2 | SM00275 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 6.82e-08 | 14 | 117 | 5 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 6.82e-08 | 14 | 117 | 5 | M750 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 2.07e-07 | 17 | 117 | 5 | M47544 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 6.61e-07 | 21 | 117 | 5 | M27137 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.68e-06 | 25 | 117 | 5 | MM14858 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 2.07e-06 | 26 | 117 | 5 | M47553 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC1 TRPA1 SPG7 FLVCR1 ATP9B APOA4 ADCY1 ADCY5 ABCA8 ADCY8 RYR3 ANO8 SLC5A11 AP2B1 SLC15A2 SLC35B4 ATP2C2 SLC39A6 ABCC10 MCOLN2 | 2.47e-06 | 736 | 117 | 20 | M27287 |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 2.52e-06 | 27 | 117 | 5 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 2.52e-06 | 27 | 117 | 5 | M47519 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 3.05e-06 | 144 | 117 | 9 | MM14501 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 5.36e-06 | 54 | 117 | 6 | M26911 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 6.21e-06 | 157 | 117 | 9 | M4904 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.66e-05 | 39 | 117 | 5 | MM14496 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | ARHGEF19 IAPP FPR2 ADCY1 ADCY5 ADCY8 CRHR1 CRHR2 ITPR3 TAS2R9 TAS2R13 GPR150 FZD10 GNAI1 GNAI3 CNR1 HCRTR2 S1PR4 | 1.84e-05 | 702 | 117 | 18 | M746 |
| Pathway | PID_S1P_META_PATHWAY | 2.42e-05 | 21 | 117 | 4 | M155 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 2.70e-05 | 43 | 117 | 5 | M29837 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 2.70e-05 | 43 | 117 | 5 | M954 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 3.03e-05 | 44 | 117 | 5 | MM15709 | |
| Pathway | REACTOME_GPER1_SIGNALING | 3.39e-05 | 45 | 117 | 5 | M45008 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 3.66e-05 | 151 | 117 | 8 | M39329 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC1 TRPA1 SPG7 FLVCR1 ATP9B APOA4 ABCA8 RYR3 ANO8 SLC5A11 AP2B1 SLC15A2 SLC35B4 ATP2C2 SLC39A6 ABCC10 MCOLN2 | 4.51e-05 | 681 | 117 | 17 | MM14985 |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 4.65e-05 | 48 | 117 | 5 | M10775 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | FPR2 ADCY1 ADCY5 ADCY8 ITPR3 TAS2R9 TAS2R13 GNAI1 GNAI3 CNR1 S1PR4 | 5.98e-05 | 314 | 117 | 11 | M600 |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 6.41e-05 | 10 | 117 | 3 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 6.41e-05 | 10 | 117 | 3 | MM14668 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 6.50e-05 | 211 | 117 | 9 | MM14502 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | ARHGEF19 IAPP FPR2 ADCY1 ADCY5 ADCY8 CRHR1 CRHR2 ITPR3 TAS2R13 GPR150 GNAI1 GNAI3 CNR1 HCRTR2 S1PR4 | 8.47e-05 | 646 | 117 | 16 | MM14962 |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.01e-04 | 90 | 117 | 6 | M6467 | |
| Pathway | KEGG_GAP_JUNCTION | 1.01e-04 | 90 | 117 | 6 | M4013 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | ACTN2 ADCY1 ADCY5 ADCY8 CHRNA7 IL1RAPL1 AP2B1 GNAI1 GNAI3 GJA10 CHRFAM7A | 1.07e-04 | 335 | 117 | 11 | MM14503 |
| Pathway | REACTOME_EICOSANOIDS | 1.16e-04 | 12 | 117 | 3 | M27129 | |
| Pathway | REACTOME_EICOSANOIDS | 1.16e-04 | 12 | 117 | 3 | MM14845 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.27e-04 | 59 | 117 | 5 | M27140 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 1.37e-04 | 60 | 117 | 5 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 1.37e-04 | 60 | 117 | 5 | M976 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.48e-04 | 61 | 117 | 5 | MM14861 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.50e-04 | 13 | 117 | 3 | M39589 | |
| Pathway | WP_LEUKOTRIENE_METABOLIC_PATHWAY | 1.50e-04 | 13 | 117 | 3 | M45552 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.60e-04 | 62 | 117 | 5 | M39653 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 1.73e-04 | 63 | 117 | 5 | M8 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.86e-04 | 64 | 117 | 5 | M5650 | |
| Pathway | PID_S1P_S1P4_PATHWAY | 1.90e-04 | 14 | 117 | 3 | M64 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 1.90e-04 | 14 | 117 | 3 | MM15842 | |
| Pathway | KEGG_MELANOGENESIS | 1.92e-04 | 101 | 117 | 6 | M7761 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 2.01e-04 | 65 | 117 | 5 | M15 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.21e-04 | 147 | 117 | 7 | MM15854 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 2.25e-04 | 104 | 117 | 6 | M738 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 2.36e-04 | 15 | 117 | 3 | M47794 | |
| Pathway | REACTOME_FATTY_ACIDS | 2.36e-04 | 15 | 117 | 3 | M27126 | |
| Pathway | PID_LPA4_PATHWAY | 2.36e-04 | 15 | 117 | 3 | M56 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 2.36e-04 | 15 | 117 | 3 | M47504 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.68e-04 | 38 | 117 | 4 | M14981 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 2.85e-04 | 70 | 117 | 5 | M8232 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 2.88e-04 | 16 | 117 | 3 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 2.88e-04 | 16 | 117 | 3 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.88e-04 | 16 | 117 | 3 | MM14492 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 2.88e-04 | 16 | 117 | 3 | M39849 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 3.04e-04 | 71 | 117 | 5 | MM14491 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 3.07e-04 | 205 | 117 | 8 | M752 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 3.48e-04 | 17 | 117 | 3 | M26995 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 3.60e-04 | 41 | 117 | 4 | M512 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 4.15e-04 | 18 | 117 | 3 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 4.15e-04 | 18 | 117 | 3 | MM14841 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 5.62e-04 | 46 | 117 | 4 | M39828 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 5.73e-04 | 20 | 117 | 3 | M759 | |
| Pathway | PID_S1P_S1P1_PATHWAY | 6.64e-04 | 21 | 117 | 3 | M103 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 6.75e-04 | 289 | 117 | 9 | MM15057 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 6.99e-04 | 85 | 117 | 5 | M3578 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 8.34e-04 | 51 | 117 | 4 | M26972 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 8.71e-04 | 134 | 117 | 6 | M29840 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 8.97e-04 | 52 | 117 | 4 | M5785 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 9.06e-04 | 90 | 117 | 5 | MM15882 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 9.52e-04 | 91 | 117 | 5 | M39426 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 9.93e-04 | 24 | 117 | 3 | M47520 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 1.11e-03 | 55 | 117 | 4 | M39763 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.26e-03 | 26 | 117 | 3 | MM14495 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.52e-03 | 101 | 117 | 5 | M1979 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.54e-03 | 60 | 117 | 4 | MM15636 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 1.57e-03 | 28 | 117 | 3 | M47647 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.74e-03 | 62 | 117 | 4 | M546 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 1.74e-03 | 29 | 117 | 3 | M47627 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX | 1.74e-03 | 29 | 117 | 3 | M39858 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.74e-03 | 29 | 117 | 3 | M47515 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.78e-03 | 154 | 117 | 6 | MM15974 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.80e-03 | 105 | 117 | 5 | MM14842 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.84e-03 | 270 | 117 | 8 | M15514 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 1.85e-03 | 8 | 117 | 2 | M47642 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 1.85e-03 | 8 | 117 | 2 | M47643 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.90e-03 | 156 | 117 | 6 | M39475 | |
| Pathway | KEGG_O_GLYCAN_BIOSYNTHESIS | 1.92e-03 | 30 | 117 | 3 | M6929 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 2.04e-03 | 108 | 117 | 5 | M17034 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 2.11e-03 | 31 | 117 | 3 | M47507 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.13e-03 | 109 | 117 | 5 | MM15164 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.19e-03 | 66 | 117 | 4 | MM14839 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | ACTN2 ADCY1 ADCY5 ADCY8 CHRNA7 IL1RAPL1 AP2B1 GNAI1 GNAI3 GJA10 | 2.21e-03 | 411 | 117 | 10 | M735 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.30e-03 | 111 | 117 | 5 | M27416 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 2.32e-03 | 32 | 117 | 3 | M47506 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.32e-03 | 32 | 117 | 3 | MM14730 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 2.37e-03 | 9 | 117 | 2 | M47641 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.38e-03 | 220 | 117 | 7 | M10320 | |
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 3.30e-09 | 14 | 156 | 5 | 14993377 | |
| Pubmed | 5.80e-09 | 6 | 156 | 4 | 12881038 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 25937212 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 37353597 | ||
| Pubmed | 1.25e-07 | 11 | 156 | 4 | 10808179 | ||
| Pubmed | ABCC1 AADAC CYP3A7 CYP4F8 CYP4F2 ABCA8 SLC15A2 CYP4F3 ABCC10 | 2.45e-07 | 193 | 156 | 9 | 19343046 | |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 11168387 | ||
| Pubmed | 8.79e-07 | 5 | 156 | 3 | 19077175 | ||
| Pubmed | 1.75e-06 | 6 | 156 | 3 | 9068972 | ||
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 12613887 | ||
| Pubmed | CYP3A7 TMEM60 CLEC5A GPR141 LMBR1 ADCY1 NPVF CRHR2 SAMD9L GALNT17 SLC35B4 MGAM2 | 6.00e-06 | 536 | 156 | 12 | 12690205 | |
| Pubmed | 7.29e-06 | 9 | 156 | 3 | 12503609 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 7.29e-06 | 9 | 156 | 3 | 17229090 | |
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 1.04e-05 | 10 | 156 | 3 | 11884542 | |
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 1.04e-05 | 10 | 156 | 3 | 8663304 | |
| Pubmed | 1.04e-05 | 10 | 156 | 3 | 16615126 | ||
| Pubmed | 1.42e-05 | 11 | 156 | 3 | 10089566 | ||
| Pubmed | 1.63e-05 | 70 | 156 | 5 | 15128046 | ||
| Pubmed | 1.74e-05 | 179 | 156 | 7 | 18577758 | ||
| Pubmed | 1.89e-05 | 12 | 156 | 3 | 10807185 | ||
| Pubmed | Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle. | 1.89e-05 | 12 | 156 | 3 | 9611134 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 26146906 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 38070724 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 34453977 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 26999808 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 27129924 | ||
| Pubmed | Sensorimotor gating and spatial learning in α7-nicotinic receptor knockout mice. | 2.00e-05 | 2 | 156 | 2 | 23521765 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 28258105 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 19344760 | ||
| Pubmed | Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling. | 2.00e-05 | 2 | 156 | 2 | 19098121 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 29114104 | ||
| Pubmed | Calmodulin-stimulated adenylyl cyclase gene deletion affects morphine responses. | 2.00e-05 | 2 | 156 | 2 | 16914643 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 33995108 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 32552811 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 24836856 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 15948184 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 15745964 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 35678315 | ||
| Pubmed | Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy. | 2.00e-05 | 2 | 156 | 2 | 27797960 | |
| Pubmed | Functional role of alpha7 nicotinic receptor in physiological control of cutaneous homeostasis. | 2.00e-05 | 2 | 156 | 2 | 12628457 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 25157794 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 37543650 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 31202708 | ||
| Pubmed | Prenatal nicotine exposure alters lung function and airway geometry through α7 nicotinic receptors. | 2.00e-05 | 2 | 156 | 2 | 22246862 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 27471776 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 22688057 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 32028688 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 30429582 | ||
| Pubmed | A transgenic mouse model reveals fast nicotinic transmission in hippocampal pyramidal neurons. | 2.00e-05 | 2 | 156 | 2 | 21501254 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 21368056 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 1400473 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 26937017 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 36603528 | ||
| Pubmed | Activation of α7nAChR Promotes Diabetic Wound Healing by Suppressing AGE-Induced TNF-α Production. | 2.00e-05 | 2 | 156 | 2 | 26650489 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 22848433 | ||
| Pubmed | Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. | 2.00e-05 | 2 | 156 | 2 | 16650968 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 35413868 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 24462939 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 29261717 | ||
| Pubmed | Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice. | 2.00e-05 | 2 | 156 | 2 | 18199426 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 22490926 | ||
| Pubmed | Calcium-stimulated adenylyl cyclases are critical modulators of neuronal ethanol sensitivity. | 2.00e-05 | 2 | 156 | 2 | 15843614 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 18222416 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 23270857 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 18077004 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 19462340 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 16923147 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 11790782 | ||
| Pubmed | Myeloid ALX/FPR2 regulates vascularization following tissue injury. | 2.00e-05 | 2 | 156 | 2 | 32513697 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 37746145 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 19631623 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 15770102 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 24326163 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 14724656 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 23811428 | ||
| Pubmed | Alpha 7 subunit of nAChR regulates migration of human mesenchymal stem cells. | 2.00e-05 | 2 | 156 | 2 | 20720594 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 17019565 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 19100751 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 35883638 | ||
| Pubmed | Chrna7 genotype is linked with alpha7 nicotinic receptor expression but not alpha7 RNA levels. | 2.00e-05 | 2 | 156 | 2 | 19368846 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 15009674 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 17959885 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 18325997 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 38253622 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 30862681 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 34514543 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 22183893 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 32057826 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 9364063 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 12606407 | ||
| Pubmed | Genetic variations in CHRNA7 or CHRFAM7 and susceptibility to dementia. | 2.00e-05 | 2 | 156 | 2 | 22300029 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 32018068 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 26206074 | ||
| Pubmed | Nicotine elicits prolonged calcium signaling along ventral hippocampal axons. | 2.00e-05 | 2 | 156 | 2 | 24349346 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 36226826 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 21143250 | ||
| Pubmed | Cholinergic modulation of appetite-related synapses in mouse lateral hypothalamic slice. | 2.00e-05 | 2 | 156 | 2 | 16319313 | |
| Pubmed | Methylglyoxal Requires AC1 and TRPA1 to Produce Pain and Spinal Neuron Activation. | 2.00e-05 | 2 | 156 | 2 | 29270106 | |
| Pubmed | Impaired synaptic plasticity in the visual cortex of mice lacking α7-nicotinic receptor subunit. | 2.00e-05 | 2 | 156 | 2 | 25797465 | |
| Pubmed | Allosteric Inhibition of Adenylyl Cyclase Type 5 by G-Protein: A Molecular Dynamics Study. | 2.00e-05 | 2 | 156 | 2 | 32957635 | |
| Interaction | S1PR4 interactions | 7.49e-06 | 137 | 147 | 8 | int:S1PR4 | |
| Interaction | FAM234B interactions | 1.55e-05 | 73 | 147 | 6 | int:FAM234B | |
| Interaction | FFAR2 interactions | 3.00e-05 | 121 | 147 | 7 | int:FFAR2 | |
| Cytoband | 16p13.1 | 6.85e-05 | 4 | 156 | 2 | 16p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 1.54e-04 | 147 | 156 | 5 | chr15q15 | |
| Cytoband | 17q24 | 5.07e-04 | 10 | 156 | 2 | 17q24 | |
| GeneFamily | Gap junction proteins | 8.11e-06 | 22 | 108 | 4 | 314 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.41e-05 | 10 | 108 | 3 | 53 | |
| GeneFamily | Corticotropin releasing hormone receptors | 3.54e-05 | 2 | 108 | 2 | 266 | |
| GeneFamily | Glycosyltransferase family 90 | 1.06e-04 | 3 | 108 | 2 | 443 | |
| GeneFamily | Solute carriers | FLVCR1 SLC35E2B SLC5A11 SLC15A2 SLC22A14 SLC10A5 SLC35B4 SLC35E2A SLC49A4 SLC39A6 | 1.28e-04 | 395 | 108 | 10 | 752 |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 2.19e-04 | 20 | 108 | 3 | 433 | |
| GeneFamily | Cytochrome P450 family 4 | 1.28e-03 | 36 | 108 | 3 | 1003 | |
| GeneFamily | ATP binding cassette subfamily C | 2.64e-03 | 13 | 108 | 2 | 807 | |
| GeneFamily | Dyneins, axonemal | 4.53e-03 | 17 | 108 | 2 | 536 | |
| CoexpressionAtlas | B cells, B.T3.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3 | PRR5 NXPE2 WDFY4 ITPR3 SAMD9L SLC15A2 SNX25 TMEM163 CD79B CYP4F3 HCRTR2 MCOLN2 | 7.24e-06 | 361 | 145 | 12 | GSM538219_500 |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | GALNTL6 WDFY4 TMEM156 CHPT1 SLC15A2 SNX25 CD79B DNAH8 MCOLN2 | 3.63e-08 | 200 | 155 | 9 | fe815824e9e4be3f3db73610e3814a7fd533da65 |
| ToppCell | mild-B_intermediate|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | GALNTL6 WDFY4 TMEM156 CHPT1 SLC15A2 SNX25 CD79B DNAH8 MCOLN2 | 3.63e-08 | 200 | 155 | 9 | 8e3132a1fe3708f725c5c4077878fb87bbea3678 |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.89e-07 | 175 | 155 | 8 | d3890bd0c570bb81434fdd1c5229891cefe2e462 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-07 | 180 | 155 | 8 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.13e-07 | 187 | 155 | 8 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.02e-07 | 199 | 155 | 8 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 163 | 155 | 7 | 5efecdd8a069a822bc9d35b407092925a865e629 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 163 | 155 | 7 | 0d94a427f86e62aba12c397c6d7b8cd297f3a0e5 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.93e-06 | 166 | 155 | 7 | 8de8f388f24436b84e19ef460476fdbda4d16abf | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-06 | 168 | 155 | 7 | ce9fae8b295c668b0959d5007a8bcd401d80e258 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-06 | 169 | 155 | 7 | 305cedbd97059029d7d2a248a8a4b6cfe281aa54 | |
| ToppCell | Bronchial_Brush-Immune-B_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.26e-06 | 170 | 155 | 7 | 53e9372cb06a2dc5c8ecb3f9af42f3c23da96431 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 171 | 155 | 7 | 584a095ddcbf78aa29527f84b46b5ad3e2edbaa9 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-B_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.95e-06 | 177 | 155 | 7 | d4db058c09012ec9fbde61277a9f86d9956de8fc | |
| ToppCell | IPF-Lymphoid-B|World / Disease state, Lineage and Cell class | 3.30e-06 | 180 | 155 | 7 | 30f9398c9b784f49470847a025bac90687e997a1 | |
| ToppCell | IPF-Lymphoid-B|IPF / Disease state, Lineage and Cell class | 3.68e-06 | 183 | 155 | 7 | e37d2c015c34471a8a54a0299e94b0371e1ada5a | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.81e-06 | 184 | 155 | 7 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-06 | 184 | 155 | 7 | 82d2daa39e3c31a74c08a5d77366740b87beb2fb | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 3.95e-06 | 185 | 155 | 7 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | BL-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.09e-06 | 186 | 155 | 7 | 27d4c38b180e4ce2bf3e7c4ad3db3a2ffca05ca8 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-06 | 186 | 155 | 7 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | (10)_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 4.39e-06 | 188 | 155 | 7 | fa1346902021c3a6557555ada0fd37b29cf9d5ec | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-06 | 188 | 155 | 7 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | (1)_B_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 4.39e-06 | 188 | 155 | 7 | 642a334f2d5b6dc9df4a9fa0558833bd37bd3c58 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.87e-06 | 191 | 155 | 7 | 6c1283d51a845cff67ed5e500f7e944165297b53 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.87e-06 | 191 | 155 | 7 | da4062a0f6d0af6d330acf11da216c64b0fa7c73 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-06 | 191 | 155 | 7 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.04e-06 | 192 | 155 | 7 | e33579a20ca86dcaf02c97273681ba5eee7561b8 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-06 | 193 | 155 | 7 | 8646e573f2d2ff175f3d02bfdf214e65f3b614d3 | |
| ToppCell | COVID-19_Mild-Lymphoid_B-B_intermediate|COVID-19_Mild / Disease group, lineage and cell class | 5.40e-06 | 194 | 155 | 7 | bf6f72a489c62cbf1a679552d8c5eaaaa0b99d33 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 194 | 155 | 7 | 0797245ebfa389a6f66874cb0f11297f1456e600 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 194 | 155 | 7 | 0241b4b88d6210b4c1b8aa99db17115b18142f01 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.58e-06 | 195 | 155 | 7 | d70b49f6b9c6c4422adb2936c837a1af7569fb0a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.58e-06 | 195 | 155 | 7 | eec187c087e432417bc346c5d3ead72f58bf3215 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.58e-06 | 195 | 155 | 7 | de23409b1b4146b8ae286850b829ec8dceed0117 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.77e-06 | 196 | 155 | 7 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.77e-06 | 196 | 155 | 7 | b1abecc0aafc09ca70a5fde624f2a998c4aa3341 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.97e-06 | 197 | 155 | 7 | da175e66d0a743a1b91d46f224b5ff1d37aa5410 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.97e-06 | 197 | 155 | 7 | 54fb207638e211f8efdb13003ae62a6b1f003b09 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.37e-06 | 199 | 155 | 7 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_intermediate|COVID-19_Mild / Disease, condition lineage and cell class | 6.37e-06 | 199 | 155 | 7 | 1c6a08d01f6c1a2a4b6587d3a4522efbd03275e1 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.59e-06 | 200 | 155 | 7 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.59e-06 | 200 | 155 | 7 | ead9eb579bb25fde05fc15602e3d05ab6617f7ac | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.59e-06 | 200 | 155 | 7 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.59e-06 | 200 | 155 | 7 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.59e-06 | 200 | 155 | 7 | c74bc12e13d002dedaaf75a2244ec111e47524e1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.65e-06 | 131 | 155 | 6 | 9ca209a8652aae603c4a867ea06b06ac51e7d189 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.55e-05 | 152 | 155 | 6 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 158 | 155 | 6 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 158 | 155 | 6 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 158 | 155 | 6 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|World / disease group, cell group and cell class (v2) | 2.08e-05 | 160 | 155 | 6 | 6722934e153b72039c3c4308557d0ef879a30638 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-05 | 162 | 155 | 6 | ee6f05620f4f4ebbebd5b098afc7c20876e3d21f | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-05 | 162 | 155 | 6 | 9e72d468fcdd0d27b517a9e36efb35d4617a88f9 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.39e-05 | 164 | 155 | 6 | 6a113191ea91d103d21c5f056b1950217688ea26 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_TNFAIP8L3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.47e-05 | 165 | 155 | 6 | cd73bba51f3f4871533c3512bdc0a1f05716344b | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 168 | 155 | 6 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 171 | 155 | 6 | 2e7cc311005958af52f39ca6c310c85b43a85aaf | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 171 | 155 | 6 | 4b599f953c8e5b947b2c8bbbf7fe6f9dc388e336 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 172 | 155 | 6 | 94093d356b0252b440deda4e1b0ac332b31513f6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-05 | 173 | 155 | 6 | ab6d3507301038f944ad59ccd848b5e6eeb76d04 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.44e-05 | 175 | 155 | 6 | 1b3510e9078eec7cfc5805043e435e9e5e0f0877 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Neutrophil|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.55e-05 | 176 | 155 | 6 | 676839d07450b313222622e0ffd305c732cbad6d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-05 | 177 | 155 | 6 | b07e6139618d888a9fd7cf43cad0d86a3f63e09e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-05 | 177 | 155 | 6 | 6376ec12322c04d5d37ec2fdc376700464cbc7fb | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-B_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.66e-05 | 177 | 155 | 6 | 320fd77c7c98e9305dcc34a168ec9d674539ed65 | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 3.66e-05 | 177 | 155 | 6 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-T_mait-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.66e-05 | 177 | 155 | 6 | 605f71515c877bb4de4121675ec8c1318a2500a7 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 178 | 155 | 6 | 9b932b677ae05ac6e12cd6ce97789f8c10e4790b | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Erythrophagocytic_macrophages|Lung / Manually curated celltypes from each tissue | 3.78e-05 | 178 | 155 | 6 | b63cee443cc1b7416112bf610d7c9d41e4fa37ed | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.02e-05 | 180 | 155 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.02e-05 | 180 | 155 | 6 | 392bc71a69653ba12de31bed4e9357f181094641 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 180 | 155 | 6 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-05 | 181 | 155 | 6 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-05 | 181 | 155 | 6 | 8fd64404e57c22c204d835fc5626f73554257b19 | |
| ToppCell | PCW_05-06-Immune_Lymphocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.15e-05 | 181 | 155 | 6 | bd99c5849bb4979c891898312cb9f602c6831b23 | |
| ToppCell | control-Lymphoid-B_cell|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.15e-05 | 181 | 155 | 6 | e414303bb90e5fe7b667c2acf9a50f8694b90e54 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.15e-05 | 181 | 155 | 6 | c8286a7ac8e3cc5aa7e92b043a08435294ea686f | |
| ToppCell | NS-control-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.28e-05 | 182 | 155 | 6 | 4b9b55154a79992112c1c467e8752c3cdbb541d9 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 182 | 155 | 6 | b8be66a867ea1bbae0820b26dbd55b68611f5ad5 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 182 | 155 | 6 | cb488f9a9b200e2557335ccf22535cd247512cdc | |
| ToppCell | Severe_COVID-19-B_cell-B_cell|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.41e-05 | 183 | 155 | 6 | 5634e528001c389efd1e380f01ad40072f60e943 | |
| ToppCell | PCW_05-06-Immune_Lymphocytic-Immune_Lymphocytic_B|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.41e-05 | 183 | 155 | 6 | ffa7f2b2929ea4bd53f3f1ae23bd27f8bb4aac47 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 183 | 155 | 6 | edb0069c66b1465dcc0bb5881417c6b17184fd74 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.55e-05 | 184 | 155 | 6 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.55e-05 | 184 | 155 | 6 | f81209e6bc01a0140f4487aa8b22eb02fbf0c39c | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Myelocyte-like|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.69e-05 | 185 | 155 | 6 | 92b9ec18ff7c53a52b87e2c2012d0b719a7ad20a | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Neutrophil|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.69e-05 | 185 | 155 | 6 | 655fb705d7a029844ecb4f6a53e948e37ee81006 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.69e-05 | 185 | 155 | 6 | 2aa5e9f6f167d27317a01d22392b59512333fa64 | |
| ToppCell | COPD-Lymphoid-B|World / Disease state, Lineage and Cell class | 4.69e-05 | 185 | 155 | 6 | 22891ed75e25ef30dfa541cb82d85e08ce07e7d9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.69e-05 | 185 | 155 | 6 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.69e-05 | 185 | 155 | 6 | 8fc357ee041bfd588986730a52ea2021b5f88941 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.69e-05 | 185 | 155 | 6 | 405bd4ba7ca7f7b625c49f1313ff946509e17c13 | |
| ToppCell | moderate-Lymphoid-B_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.83e-05 | 186 | 155 | 6 | fd2c4c3e8929ca5d64f6c5064e5f3d3d6ba07b5f | |
| ToppCell | Children_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.83e-05 | 186 | 155 | 6 | aa576748921a318798b911a611f05319b95e8d5e | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.97e-05 | 187 | 155 | 6 | 9d298f43ae81d72091b31aaa6df41046d4aa31c5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 187 | 155 | 6 | 7c44cec1c26ca5907a495f2d7e633410e2e9728f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.97e-05 | 187 | 155 | 6 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-B_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.12e-05 | 188 | 155 | 6 | e9ed34cfea1d93eaa8e63d5b5dbb64f1520d9c4c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-05 | 189 | 155 | 6 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| Drug | halothane | CYP3A7 CACNG1 CYP4F8 TRPA1 CYP4F2 PKD1L3 ADCY1 ADCY5 ADCY8 CHRNA7 RYR3 ITPR3 GJD3 ATP2C2 CYP26C1 CYP4F3 CHRFAM7A | 3.17e-11 | 314 | 150 | 17 | CID000003562 |
| Drug | verapamil | ABCC1 CYP3A7 CACNG1 TRPA1 APOA4 PKD1L3 ADCY1 ADCY5 ABCA8 ADCY8 CHRNA7 RYR3 ITPR3 ATP2C2 PLA2G1B GNAI1 CHRFAM7A ABCC10 | 4.20e-09 | 490 | 150 | 18 | CID000002520 |
| Drug | lanthanum | CACNG1 TRPA1 PKD1L3 ADCY1 ADCY5 ADCY8 RYR3 ITPR3 ATP2C2 PLA2G1B | 2.38e-08 | 136 | 150 | 10 | CID000023926 |
| Drug | caffeine | CYP3A7 CACNG1 CYP4F8 TRPA1 SYNE1 GDPD2 CYP4F2 PKD1L3 ADCY1 ADCY5 ADCY8 CHRNA7 RYR3 ITPR3 ATP2C2 CYP26C1 CYP4F3 CHRFAM7A | 3.45e-08 | 562 | 150 | 18 | CID000002519 |
| Drug | NSC7524 | CACNG1 TRPA1 PKD1L3 ADCY1 ADCY5 ADCY8 CHRNA7 RYR3 ITPR3 CHRFAM7A S1PR4 | 3.57e-08 | 182 | 150 | 11 | CID000005657 |
| Drug | AC1L1AL2 | 7.13e-08 | 115 | 150 | 9 | CID000001035 | |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; PC3; HT_HG-U133A | PRR5 ATP9B TNFRSF17 ADCY1 PTPRT RYR3 IL1RAPL1 DEFA5 DMC1 CPSF1 CD79B | 8.04e-08 | 197 | 150 | 11 | 4315_UP |
| Drug | AC1MUNZL | 8.28e-08 | 56 | 150 | 7 | CID003643892 | |
| Drug | tolbutamide | CYP3A7 CYP4F8 HK1 IAPP CYP4F2 ADCY1 ADCY5 ADCY8 SLC5A11 CYP26C1 CYP4F3 | 8.47e-08 | 198 | 150 | 11 | CID000005505 |
| Drug | felodipine | CYP3A7 CACNG1 CYP4F8 TRPA1 CYP4F2 PKD1L3 RYR3 ITPR3 CYP26C1 CYP4F3 | 1.86e-07 | 169 | 150 | 10 | CID000003333 |
| Drug | tienilic acid | 1.87e-07 | 93 | 150 | 8 | CID000038409 | |
| Drug | AC1L1KS5 | CACNG1 TRPA1 FPR2 PKD1L3 ADCY1 ADCY5 ADCY8 CRHR1 CRHR2 RYR3 ITPR3 ATP2C2 PLA2G1B | 3.48e-07 | 334 | 150 | 13 | CID000005631 |
| Drug | myo-inositol | CACNG1 TRPA1 ERN1 FPR2 PKD1L3 ADCY1 ADCY5 ADCY8 CHRNA7 RYR3 ITPR3 SLC5A11 CHPT1 AP2B1 ATP2C2 PLA2G1B CD79B GPRC5D CHRFAM7A S1PR4 | 3.98e-07 | 811 | 150 | 20 | CID000000892 |
| Drug | baclofen | 5.77e-07 | 191 | 150 | 10 | CID000002284 | |
| Drug | NSC759576 | CYP3A7 CACNG1 TRPA1 PKD1L3 ADCY1 ADCY5 ADCY8 RYR3 ITPR3 PLA2G1B | 5.77e-07 | 191 | 150 | 10 | CID000003075 |
| Drug | Bay K 8644 | 6.92e-07 | 150 | 150 | 9 | CID000002303 | |
| Drug | cyclophorine | ABCC1 CYP3A7 CACNG1 TRPA1 FPR2 KLK14 APOA4 PKD1L3 ADCY1 ADCY5 ADCY8 RYR3 ITPR3 ABCC10 | 9.26e-07 | 426 | 150 | 14 | CID000002909 |
| Drug | tetracaine | 1.90e-06 | 88 | 150 | 7 | CID000005411 | |
| Drug | GTP[S] | CACNG1 IAPP FPR2 PKD1L3 ADCY1 ADCY5 ADCY8 CRHR1 RYR3 ITPR3 MGP PLA2G1B GNAI3 NME6 CNR1 HCRTR2 | 1.92e-06 | 591 | 150 | 16 | CID000001764 |
| Drug | CNS 1145 | 2.37e-06 | 33 | 150 | 5 | CID000190902 | |
| Drug | IHC-64 | 2.37e-06 | 33 | 150 | 5 | CID000162753 | |
| Drug | TMB-8 | 2.62e-06 | 176 | 150 | 9 | CID000005494 | |
| Drug | papaverine | 2.62e-06 | 176 | 150 | 9 | CID000004680 | |
| Drug | U46619 | CACNG1 CYP4F8 TRPA1 PKD1L3 ADCY1 ADCY5 ADCY8 RYR3 ITPR3 PTPRM PLA2G1B | 3.12e-06 | 285 | 150 | 11 | CID000005618 |
| Drug | isotetrandrine | 3.66e-06 | 97 | 150 | 7 | CID000005422 | |
| Drug | nifedipine | CYP3A7 CACNG1 CYP4F8 TRPA1 CYP4F2 PKD1L3 RYR3 ITPR3 ATP2C2 CYP26C1 PLA2G1B CYP4F3 LYZ | 3.89e-06 | 415 | 150 | 13 | CID000004485 |
| Drug | nitrendipine | 3.92e-06 | 98 | 150 | 7 | CID000004507 | |
| Drug | AAGTP | 4.05e-06 | 64 | 150 | 6 | CID000656407 | |
| Drug | tacrine | 5.20e-06 | 144 | 150 | 8 | CID000001935 | |
| Drug | 4-bromophenol | 6.85e-06 | 70 | 150 | 6 | CID000007808 | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 7.13e-06 | 199 | 150 | 9 | 3618_UP | |
| Drug | oxotremorine | 7.49e-06 | 108 | 150 | 7 | CID000004630 | |
| Drug | glibenclamide | RALGAPA1 ABCC1 HK1 IAPP APOA4 ADCY1 ADCY5 ABCA8 ADCY8 LYZ ALOX5AP ABCC10 | 9.04e-06 | 382 | 150 | 12 | CID000003488 |
| Drug | ethosuximide | 9.47e-06 | 74 | 150 | 6 | CID000003291 | |
| Drug | 1,4-diaminocyclohexane | 9.62e-06 | 7 | 150 | 3 | CID000018374 | |
| Drug | AC1NBU2S | 1.27e-05 | 117 | 150 | 7 | CID004473765 | |
| Drug | paraoxon | 1.35e-05 | 164 | 150 | 8 | CID000009395 | |
| Drug | AC1L1KC5 | CACNG1 TRPA1 ERN1 IAPP PKD1L3 CHRNA7 RYR3 ITPR3 ATP2C2 SLC49A4 PLA2G1B LYZ CHRFAM7A CNR1 | 1.44e-05 | 541 | 150 | 14 | CID000005428 |
| Drug | AC1L1EV8 | 1.53e-05 | 8 | 150 | 3 | CID000002964 | |
| Drug | probenecid | 1.76e-05 | 123 | 150 | 7 | CID000004911 | |
| Drug | carbonyl cyanide m-chlorophenylhydrazone | 1.95e-05 | 125 | 150 | 7 | CID000002603 | |
| Drug | atropine sulfate | TMEM60 IAPP ADCY1 ADCY5 ADCY8 CRHR1 CHRNA7 CRHR2 MGP PLA2G1B CHRFAM7A | 1.99e-05 | 347 | 150 | 11 | CID000003661 |
| Drug | diosmetin | 2.11e-05 | 85 | 150 | 6 | CID005281612 | |
| Drug | 14,15-dihydroforskolin | 2.29e-05 | 9 | 150 | 3 | CID000194193 | |
| Drug | NSC406942 | HK1 CLEC5A GALNT7 ADCY1 ADCY5 ADCY8 CRHR1 RYR3 RNASE1 SNX25 ATP2C2 LYZ DYNC1H1 CNR1 | 2.33e-05 | 565 | 150 | 14 | CID000001115 |
| Drug | LS-63783 | CYP3A7 CYP4F8 ERN1 FPR2 CYP4F2 ADCY1 LIN9 ADCY5 ADCY8 CHRNA7 CYP26C1 PLA2G1B CYP4F3 LYZ CHRFAM7A ALOX5AP CNR1 | 2.34e-05 | 804 | 150 | 17 | CID000000231 |
| Drug | propanol | 2.58e-05 | 53 | 150 | 5 | CID000001031 | |
| Drug | lithium chromate | SYNE1 APOA4 ADCY1 ADCY5 ADCY8 CRHR1 CHRNA7 ATP2C2 PLA2G1B CHRFAM7A | 2.79e-05 | 296 | 150 | 10 | CID000026627 |
| Drug | SM-10906 | 2.82e-05 | 27 | 150 | 4 | CID006442261 | |
| Drug | propranolol | CACNG1 TRPA1 APOA4 PKD1L3 ADCY1 ADCY5 ADCY8 CHRNA7 RYR3 ITPR3 PLA2G1B CHRFAM7A | 3.19e-05 | 434 | 150 | 12 | CID000004946 |
| Drug | 2',5'-dd3'-FSBA | 3.25e-05 | 10 | 150 | 3 | CID003081206 | |
| Drug | NC-5Z | 3.25e-05 | 10 | 150 | 3 | CID003035914 | |
| Drug | Guanabenz | 3.25e-05 | 10 | 150 | 3 | ctd:D006143 | |
| Drug | desacetylnantradol | 3.28e-05 | 28 | 150 | 4 | CID000125211 | |
| Drug | Cinildipine | 3.38e-05 | 56 | 150 | 5 | CID000002752 | |
| Drug | pirenzepine | 3.52e-05 | 93 | 150 | 6 | CID000004848 | |
| Drug | phenylalanyl corticotropin-releasing factor (12-41) | 4.31e-05 | 2 | 150 | 2 | ctd:C113202 | |
| Drug | 2-nitro-4-carboxyphenylsulfenyl chloride | 4.31e-05 | 2 | 150 | 2 | CID000152268 | |
| Drug | TAP2-Br | 4.31e-05 | 2 | 150 | 2 | CID003081339 | |
| Drug | Sb25 | 4.31e-05 | 2 | 150 | 2 | CID000058453 | |
| Drug | palmitoylhomocysteine | 4.31e-05 | 2 | 150 | 2 | CID000131290 | |
| Drug | dihydroalprenolol | 4.34e-05 | 30 | 150 | 4 | CID000043216 | |
| Drug | AC1L40QM | 4.45e-05 | 11 | 150 | 3 | CID000099213 | |
| Drug | B-Mlvp | 4.45e-05 | 11 | 150 | 3 | CID000195648 | |
| Drug | AC1NY9KD | 4.45e-05 | 11 | 150 | 3 | CID005771741 | |
| Drug | nilvadipine | 4.74e-05 | 60 | 150 | 5 | CID000004494 | |
| Drug | Clidinium bromide [3485-62-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 4499_UP | |
| Drug | AC1L3P1W | 4.96e-05 | 31 | 150 | 4 | CID000119574 | |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 5741_UP | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; PC3; HT_HG-U133A | 5.02e-05 | 197 | 150 | 8 | 4654_UP | |
| Drug | nimodipine | 5.06e-05 | 145 | 150 | 7 | CID000004497 | |
| Drug | nicardipine | 5.06e-05 | 145 | 150 | 7 | CID000004473 | |
| Drug | Dantrolene-13C3 | 5.06e-05 | 145 | 150 | 7 | CID000002951 | |
| Drug | IAA-94 | 5.13e-05 | 61 | 150 | 5 | CID000003667 | |
| Drug | otenzepad | 5.13e-05 | 61 | 150 | 5 | CID000107867 | |
| Drug | carbachol | CACNG1 TRPA1 IAPP PKD1L3 ADCY1 ADCY5 ADCY8 CHRNA7 RYR3 ITPR3 ATP2C2 PLA2G1B GNAI3 CHRFAM7A CNR1 | 5.14e-05 | 688 | 150 | 15 | CID000002551 |
| Drug | GI-3 | 5.52e-05 | 147 | 150 | 7 | CID011957433 | |
| Drug | lercanidipine | 6.00e-05 | 63 | 150 | 5 | CID000065866 | |
| Drug | mangrove | HK1 ERN1 APOA4 ADCY1 LIN9 ADCY5 ADCY8 CHRNA7 MGP CLPS PLA2G1B CHRFAM7A | 6.59e-05 | 468 | 150 | 12 | CID000000965 |
| Drug | procaine | 7.11e-05 | 153 | 150 | 7 | CID000004914 | |
| Drug | benzilate | 7.51e-05 | 66 | 150 | 5 | CID000201538 | |
| Drug | FCE 23884 | 7.64e-05 | 13 | 150 | 3 | CID000065898 | |
| Drug | AC1L1BJN | 7.64e-05 | 13 | 150 | 3 | CID000001467 | |
| Drug | sclareol glycol | 7.64e-05 | 13 | 150 | 3 | CID000091915 | |
| Drug | AC1MIXC3 | 7.64e-05 | 13 | 150 | 3 | CID003081671 | |
| Drug | nantradol hydrochloride | 7.64e-05 | 13 | 150 | 3 | CID000047652 | |
| Drug | nickel | CACNG1 TRPA1 TNFRSF17 PKD1L3 ADCY1 ADCY5 ADCY8 RYR3 ITPR3 RNASE1 ATP2C2 LYZ CNR1 | 7.71e-05 | 552 | 150 | 13 | CID000000934 |
| Drug | gallopamil | 8.07e-05 | 67 | 150 | 5 | CID000001234 | |
| Drug | propoxyphene | 8.07e-05 | 67 | 150 | 5 | CID000010100 | |
| Drug | AC1NSKJI | 8.66e-05 | 68 | 150 | 5 | CID005311391 | |
| Drug | AC1L1DSZ | 9.05e-05 | 36 | 150 | 4 | CID000002494 | |
| Drug | NO-cAMP | 9.29e-05 | 69 | 150 | 5 | CID006426615 | |
| Drug | AC1L2AC7 | 9.29e-05 | 69 | 150 | 5 | CID000068733 | |
| Drug | EN-1530 | 9.81e-05 | 278 | 150 | 9 | CID000004425 | |
| Drug | H-8105 | 1.09e-04 | 282 | 150 | 9 | CID000164531 | |
| Drug | carteolol | 1.14e-04 | 72 | 150 | 5 | CID000002583 | |
| Drug | SKF 75670 | 1.20e-04 | 15 | 150 | 3 | CID000173870 | |
| Drug | aa373 | 1.20e-04 | 15 | 150 | 3 | CID000191672 | |
| Drug | BMY 42393 | 1.20e-04 | 15 | 150 | 3 | CID000131961 | |
| Drug | AC1L2AAS | 1.20e-04 | 15 | 150 | 3 | CID000068714 | |
| Disease | Withdrawal Symptoms | 1.13e-05 | 58 | 149 | 5 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 1.13e-05 | 58 | 149 | 5 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.13e-05 | 58 | 149 | 5 | C0038587 | |
| Disease | functional colonic disease (biomarker_via_orthology) | 7.57e-05 | 3 | 149 | 2 | DOID:3877 (biomarker_via_orthology) | |
| Disease | FEV change measurement, response to montelukast | 7.57e-05 | 3 | 149 | 2 | EFO_0005921, EFO_0007612 | |
| Disease | glycosyltransferase-like protein LARGE1 measurement | 1.51e-04 | 4 | 149 | 2 | EFO_0802578 | |
| Disease | Bipolar Disorder | SYNE1 ADCY8 CRHR1 CHRNA7 CRHR2 PLA2G1B GPRC5D DNAH8 CHRFAM7A CNR1 | 1.64e-04 | 477 | 149 | 10 | C0005586 |
| Disease | Cocaine-Related Disorders | 3.27e-04 | 117 | 149 | 5 | C0236736 | |
| Disease | cognitive disorder (implicated_via_orthology) | 3.75e-04 | 6 | 149 | 2 | DOID:1561 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (biomarker_via_orthology) | 3.75e-04 | 6 | 149 | 2 | DOID:7148 (biomarker_via_orthology) | |
| Disease | Cocaine Abuse | 4.76e-04 | 127 | 149 | 5 | C0009171 | |
| Disease | pulse pressure measurement, anxiety | 5.23e-04 | 7 | 149 | 2 | EFO_0005230, EFO_0005763 | |
| Disease | peripheral neuropathy | 5.23e-04 | 7 | 149 | 2 | EFO_0003100 | |
| Disease | Hyperkinesia | 5.62e-04 | 32 | 149 | 3 | C3887506 | |
| Disease | Hyperkinesia, Generalized | 5.62e-04 | 32 | 149 | 3 | C0751217 | |
| Disease | amino acid measurement | GALNTL6 SYNE1 NXPE2 RYR3 CYP26C1 CD79B UNC13C GNAI1 AP4B1 MGAM2 MCOLN2 | 6.86e-04 | 678 | 149 | 11 | EFO_0005134 |
| Disease | irritable bowel syndrome (biomarker_via_orthology) | 6.95e-04 | 8 | 149 | 2 | DOID:9778 (biomarker_via_orthology) | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 6.95e-04 | 8 | 149 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | disease recurrence, malaria | 6.95e-04 | 8 | 149 | 2 | EFO_0001068, EFO_0004952 | |
| Disease | Cocaine Dependence | 7.17e-04 | 139 | 149 | 5 | C0600427 | |
| Disease | post-traumatic stress disorder symptom measurement | 8.05e-04 | 82 | 149 | 4 | EFO_0008535 | |
| Disease | Kunitz-type protease inhibitor 1 measurement | 8.91e-04 | 9 | 149 | 2 | EFO_0008199 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 8.91e-04 | 9 | 149 | 2 | EFO_0800562 | |
| Disease | Anxiety States, Neurotic | 1.44e-03 | 44 | 149 | 3 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 1.44e-03 | 44 | 149 | 3 | C1279420 | |
| Disease | Anxiety Disorders | 1.44e-03 | 44 | 149 | 3 | C0003469 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.53e-03 | 45 | 149 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.62e-03 | 12 | 149 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 1.90e-03 | 13 | 149 | 2 | EFO_0800284 | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 2.21e-03 | 14 | 149 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | complement factor H-related protein 1 measurement | 2.88e-03 | 56 | 149 | 3 | EFO_0600054 | |
| Disease | Tactile Amnesia | 3.28e-03 | 17 | 149 | 2 | C0750906 | |
| Disease | Amnestic State | 3.28e-03 | 17 | 149 | 2 | C0750907 | |
| Disease | Dissociative Amnesia | 3.28e-03 | 17 | 149 | 2 | C0236795 | |
| Disease | Hysterical amnesia | 3.28e-03 | 17 | 149 | 2 | C0233750 | |
| Disease | Temporary Amnesia | 3.28e-03 | 17 | 149 | 2 | C0233796 | |
| Disease | Amnesia | 3.28e-03 | 17 | 149 | 2 | C0002622 | |
| Disease | Global Amnesia | 3.28e-03 | 17 | 149 | 2 | C0262497 | |
| Disease | Anorexia | 3.67e-03 | 18 | 149 | 2 | C0003123 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 4.02e-03 | 63 | 149 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | neck circumference | 4.09e-03 | 19 | 149 | 2 | EFO_0011043 | |
| Disease | schizophrenia (implicated_via_orthology) | 4.98e-03 | 68 | 149 | 3 | DOID:5419 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IMARVLFVLIVLSQL | 431 | Q0P6H9 | |
| KRIILFLFLMSVAGI | 116 | P20292 | |
| LRLNSVLKLAVLLIM | 851 | P40145 | |
| VLKLAVLLIMIAIYA | 856 | P40145 | |
| FRNGLKLMLLLEVIS | 66 | P35609 | |
| VLSAVKVLMKFLELL | 256 | P63010 | |
| ILVLVRALKSMTFLL | 231 | Q96P56 | |
| MGRKSLYLLIVGILI | 1 | P22760 | |
| LTILFIFRMLVLRVA | 26 | Q969M2 | |
| AVKMELLTALLRLFL | 471 | Q9Y6B7 | |
| GKLVLMLAIELIYVL | 931 | O95622 | |
| IFKLLIIDSIMALFR | 216 | Q14565 | |
| TVLLYRKLGIILMMV | 1081 | A7MBM2 | |
| TLKDGIIMIQTLLII | 156 | P40259 | |
| LSRALILKILMSAAI | 801 | O75185 | |
| VRIILLSYGKSMSLI | 316 | O95450 | |
| ITVLLSLTVFMLLVA | 266 | P36544 | |
| RFLPKVMLALLVSVS | 396 | Q9HCE9 | |
| LKEMLATLLITRQFL | 466 | Q9HCE9 | |
| MLKVRVTLFCILAGI | 6 | Q06432 | |
| IIAIIRAMGRLKIDF | 81 | P63096 | |
| MAVRALKLLTTLLAV | 1 | Q32P28 | |
| GLVGVISILFLLVKM | 31 | Q7Z602 | |
| IRTLAMVAKGRAILL | 1526 | Q14573 | |
| FLILPFQRITRLKML | 511 | Q8IW93 | |
| MFLKAVVLTLALVAV | 1 | P06727 | |
| GIFLLVVVFVLCRKM | 4191 | Q14517 | |
| KVFTALALVRMLILP | 536 | Q5T3U5 | |
| KRPLSLVITFFMLLS | 86 | O60320 | |
| MKGELLLFSSVIVLL | 1 | Q9HBL6 | |
| EFLIQVTRLSKILMI | 341 | Q5TKA1 | |
| ILRAASLVIMKSLEI | 381 | Q8NG48 | |
| MKALIVLGLVLLSVT | 1 | P61626 | |
| LLRMGLAFLVLVALV | 256 | O76036 | |
| IIAIIRAMGRLKIDF | 81 | P08754 | |
| MARKLSVLEVLLIIF | 1 | Q2M2H8 | |
| KMFLLLTALQVLAIA | 16 | Q9P0G3 | |
| LKVAITMLTARGIIR | 191 | P25090 | |
| KGIRARILETLVMLL | 141 | Q8WVP7 | |
| TKALFLALVALSIVM | 381 | O43861 | |
| FVLTMLLRMLVIVLA | 26 | Q96KN9 | |
| FILAADVMKSISLLR | 1221 | Q10570 | |
| TLSLLMVCGVLILVK | 436 | P29376 | |
| MRLKNLTFIIILIIS | 1 | P05160 | |
| LMITVAGLKLLRSSF | 1391 | Q96RV3 | |
| LRNMLVTGEIKVILI | 496 | Q9NZN1 | |
| VAKMGLILAIRSILL | 141 | Q8NH64 | |
| LLGNSMIFLVIITKR | 41 | Q8NGJ9 | |
| GVLMTLVFVLLLVKR | 186 | A6NFY4 | |
| VLLMTLKIDLQRGTV | 3761 | Q96JB1 | |
| LVSMLVVFLVSTRKI | 351 | Q9H6R4 | |
| VFLFNIVRILMTKLR | 281 | Q13324 | |
| KVLLLLIMLLVAAGL | 121 | Q9HCC8 | |
| MSFRKVNIIILVLAV | 1 | Q68CQ7 | |
| KFILISSLAILLMVS | 231 | Q9HC73 | |
| MEKILILLLVALSVA | 1 | P04118 | |
| MRTIAILAAILLVAL | 1 | Q01523 | |
| VRLILVKMAKEGLLF | 306 | P19367 | |
| KNMLLSVAIFILLTL | 76 | Q9P0B6 | |
| ITVLLSLTVFMLLVA | 176 | Q494W8 | |
| MGILKLQVFLIVLSV | 1 | P10997 | |
| MFIIILLGVMLTIKR | 756 | O14522 | |
| KELALFSLSILVIMV | 196 | Q8NGX3 | |
| LRVILFMIILSGNLS | 26 | Q8WZ92 | |
| KTARMLMIVLLVFAI | 301 | O43614 | |
| KLEKLMVRIGLFSVL | 436 | Q9ULW2 | |
| KFVLSVLRLLLVTMG | 496 | Q7Z6J6 | |
| LAIFFRVSSLPKMIL | 741 | Q08828 | |
| VTILLLLAFLFLMRK | 36 | Q9NZD1 | |
| LKDMATIILSTFLLI | 441 | O75460 | |
| LTILFIFRMLVLGVA | 26 | P57773 | |
| LRITVLLTSFLMVLG | 116 | Q96SL1 | |
| MRLKIGFILRSLLVV | 1 | Q86SF2 | |
| AEMKVVLALTLLRFR | 476 | P98187 | |
| MASLRRVKVLLVLNL | 1 | Q6IS24 | |
| RMDIRLAKTLVLILV | 336 | P21554 | |
| KALTFRMAARILLGL | 186 | Q6V0L0 | |
| AEMKVVLALTLLRFR | 476 | P78329 | |
| LFNIVRILMTKLRAS | 316 | P34998 | |
| LVVMLIFRILVLATV | 26 | Q8N144 | |
| MFIGIILTALIKSDL | 501 | Q9Y5Y0 | |
| ELTRLLPLMFVKITI | 116 | Q8NEG0 | |
| LIRLVGIMLLLYVKQ | 421 | P32019 | |
| ITFAMLLARIKLKGT | 3881 | Q14204 | |
| VVLMKILQVLRTLLL | 131 | Q92538 | |
| AEMKVVLGLTLLRFR | 476 | Q08477 | |
| RFALVNMKLALVRVL | 446 | P24462 | |
| MRLKLFSILSTVLLR | 621 | Q86Y56 | |
| LTKIMRLKIVALVTI | 1701 | Q9P225 | |
| ILVLMLREFSLAATV | 481 | Q9Y267 | |
| QLIMDVKALTRVLFL | 291 | Q16348 | |
| ARRLLKTVLMILLAF | 246 | O95977 | |
| GLTKIETLMLFRISK | 2216 | Q6ZTR5 | |
| MKSLILLAILAALAV | 1 | P08493 | |
| LKIVMVTTQLVRFGL | 71 | Q8IZK6 | |
| LLFVIIFLGVVLVMK | 751 | P28827 | |
| LMLIILVALLMLVFR | 4401 | Q685J3 | |
| LVALLMLVFRSKREV | 4406 | Q685J3 | |
| TMLLATFLIQLERRK | 116 | P33527 | |
| LVIALVQLAKAVLRM | 111 | Q9Y5Y5 | |
| KRFLQMTLLFTVALI | 6 | Q49A17 | |
| VNKVILMILLGTLVF | 126 | Q9NYV9 | |
| ILLFTMLLRLKHVIS | 51 | A0A1B0GWG4 | |
| LIANMILGIIILKKR | 101 | Q969S0 | |
| IKAIMALVAAILLLV | 116 | O75379 | |
| RLLIIILIIVLDMGF | 216 | Q9NX52 | |
| LTVLVFLTLSVVVMK | 576 | Q6UWJ1 | |
| VVVMKFLLAALVLSL | 586 | Q6UWJ1 | |
| MILTETLFRKIISFA | 6641 | Q8NF91 | |
| KGTLVLIIYELLLLM | 101 | Q5T9Z0 | |
| NAIARKLLLMLTFIL | 16 | Q96DL1 | |
| LRIMLAEILTTKVLK | 126 | Q9H3E2 | |
| LLTKGMVILRDKIRF | 91 | P85299 | |
| NIMTRGKFLVVFLLL | 536 | Q8IVG5 | |
| MLISRNKLILLLGIV | 1 | Q7RTZ1 | |
| VQSLKMSLLLALLFV | 291 | Q8NGU9 | |
| VMATLRLLRLLVKHA | 1786 | Q96Q15 | |
| SIILISFILLGLDMK | 1506 | Q7Z443 | |
| ELQRFITLSKRLLVM | 46 | Q9Y6E7 | |
| LMRFATVVLGLVSLK | 151 | P0CK97 | |
| ELMIVGRVFVLLLVL | 416 | Q8WWX8 | |
| MKSIILFVLSLLLIL | 1 | Q02383 | |
| MKLLVLAVLLTVAAA | 1 | P04054 | |
| IVEMLFSRGLVKVLF | 646 | Q15477 | |
| RLRTLLVIAVVMSLL | 141 | Q9UQ90 | |
| MIRKLFIVLLLLLVT | 1 | Q5PT55 | |
| MALEKSLVRLLLLVL | 1 | P07998 | |
| LTKLLIMKILRDTGV | 656 | O60287 | |
| MARKLSVILILTFAL | 1 | Q13433 | |
| LSLVALAFLMSILVK | 311 | O94911 | |
| IVVVLKVVGMTLFLL | 11 | Q9NY25 | |
| IGLIIILAIMIYKKS | 271 | Q8WUD6 | |
| MTKTALLKLFVAIVI | 1 | Q8N614 | |
| MFSDEILLSLTRKVL | 216 | Q7Z4H8 | |
| MVGQRVLLLVAFLLS | 1 | Q6NUS8 | |
| VFMIRTLRLKILADA | 261 | Q5BJH7 | |
| VMLEVILKTLLRSTV | 861 | O75762 | |
| DTILLVLLIVKMAGR | 46 | Q9H2L4 | |
| VGMSVLLAKERLLLA | 346 | Q86VN1 | |
| QMLLVLLRVTESVLK | 581 | Q6GYQ0 | |
| VDLLTSITFFRMKVL | 1516 | Q8NB66 | |
| ILSMIIIRTLRKDIA | 296 | Q92544 | |
| MEIISSKLFILLTLA | 1 | Q9HCQ7 | |
| AVRLLILILKNMEGV | 406 | Q9UJ98 | |
| INKVMLAILLGSFLI | 126 | Q9NYW1 | |
| LLDIAMGFKTLRTIL | 4646 | Q15413 | |
| MKLKQRVVLLAILLV | 1 | O75063 | |
| VMLRIVVTLLKGSVR | 546 | Q6ZS81 | |
| MLTLLTSAKVLILVL | 266 | D6R901 | |
| ILSNKFLIVRMRELL | 36 | O75414 | |
| LMRFATVVLGLVSLK | 151 | P0CK96 | |
| KSLSVILLVVALAML | 176 | Q9H0V1 | |
| FTILLRFVIMLALNI | 171 | Q8N755 | |
| RIFMDAILLSLTRKV | 211 | Q6UW63 | |
| MLTLLTSAKVLILVL | 266 | C9JPN9 | |
| MLDKIISIFIIFLLV | 456 | Q9H330 | |
| SLTVLGLRMLFAKTV | 126 | B7Z8K6 | |
| SQTLLGIIVRMKFLL | 201 | Q9H7D7 | |
| LVKLIVLMFSTLLLV | 236 | Q6ZXV5 | |
| ISLAVFVLMFLLRKI | 66 | Q02223 | |
| SILAVLKFMLGKVLT | 201 | Q8TC26 | |
| IFTLKGLDSLVAIMR | 256 | A6NCI4 |